Search Clinical Trials

Search results for All Clinical Studies.

Found 476 clinical studies.

• Patient Reported Symptom Dental Infection Extreme Learning Machine

  • Investigator: Eric Holmes
  • Posted Date: Jun 17, 2025
  • Type of Study: Observational/Survey

• Maternal Experience Of Obstetric Care For Hypertensive Disorders Of Pregnancy

  • Investigator: Ardythe Morrow
  • Posted Date: Jun 9, 2025
  • Type of Study: Observational/Survey

• A Phase 3, Randomized, Open-Label Study Of Nivolumab + Relatlimab Fixed-Dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy As First-Line Treatment For Participants With Non-Squamous (Nsq), Stage Iv Or Recurrent Non-Small Cell Lung C

  • Investigator: Jennifer Leddon
  • Posted Date: Jun 6, 2025
  • Type of Study: Drug

• A Phase 3 Randomized, Open-Label Clinical Study To Evaluate The Pharmacokinetics And Safety Of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (Mk-3475A) Versus Intravenous Pembrolizumab, In The First-Line Treatment Of Participants With Metasta

  • Investigator: Christopher Lemmon
  • Posted Date: Jun 6, 2025
  • Type of Study: Drug

• A Multicenter Parallel 2 Cohort Phase 2 Study Of Lp-168 And Obinutuzumab For Previously Treated, And T474 Gatekeeper Mutant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Cll/Sll) And Variants Of This

  • Investigator: Zulfa Omer
  • Posted Date: Jun 6, 2025
  • Type of Study: Drug

• A Phase 3 Single-Arm Study Of Ugn-104 For The Treatment Of Low-Grade Upper Tract Urothelial Cancer

  • Investigator: Alberto Martini
  • Posted Date: Jun 6, 2025
  • Type of Study: Drug

• A Phase 1A/1B Open-Label, Multicenter, Dose Escalation, And Dose Expansion Trial To Evaluate The Safety And Activity Of Tev-56278, As A Monotherapy And In Combination With Pembrolizumab In Participants With Selected Locally Advanced Or Metastatic Solid Tu

  • Investigator: Jennifer Leddon
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• The Primary Purpose Of The Study Is To Assess How Well Amivantamab Subcutaneous (Sc) Administration In Combination With Lazertinib Or In Combination With Chemotherapy Works (Antitumor Activity) In Participants With Epidermal Growth Factor Receptor Mutated

  • Investigator: Christopher Lemmon
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• Single-Arm Study Of Toripalimab In Combination With Cisplatin And Gemcitabine In Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• Phase 1 Trial Of Iadademstat In Combination With Venetoclax And Azacitidine In Patients With Treatment Naive Aml

  • Investigator: Emily Curran
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• Phase 1 Study Of Ze50-0134 In Relapsed And Refractory Chronic Lymphocytic Leukemia (Cll), Small Lymphocytic Lymphoma (Sll), And Select Low-Grade Lymphomas

  • Investigator: Zulfa Omer
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• A Phase 3, Randomized, Open-Label Study To Compare The Efficacy And Safety Of Anitocabtagene Autoleucel Versus Standard Of Care Therapy In Participants With Relapsed/Refractory Multiple Myeloma

  • Investigator: Edward Faber
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• A Phase I Dose Finding And Phase II Randomized Trial Of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy In Patients With Extensive-Stage Small Cell Lung Cancer

  • Investigator: Jennifer Leddon
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• A Phase 1B/2, Open-Label, Safety And Efficacy Study Of Epcoritamab (Gen3013; Duobody®-Cd3 X Cd20) In Relapsed/Refractory Chronic Lymphocytic Leukemia And Richter’S Syndrome

  • Investigator: John Byrd
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• Study To Evaluate Karxt For Treating Manic Episodes In Bipolar-I Disorder

  • Investigator: Caleb Adler
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• A Phase III, Randomized, Double-Blind, Multicenter, Global Study Of Rilvegostomig Or Pembrolizumab In Combination With Platinum-Based Chemotherapy For The First-Line Treatment Of Patients With Metastatic Squamous Non-Small Cell Lung Cancer Whose Tumors Ex

  • Investigator: Jennifer Leddon
  • Posted Date: May 19, 2025
  • Type of Study: Drug

• Peerless II Trial

  • Investigator: Rishi Sukhija
  • Posted Date: May 15, 2025
  • Type of Study: Device

• Integra D

  • Investigator: Srinivas Rajsheker
  • Posted Date: May 15, 2025
  • Type of Study: Device

• Artemis - Ziltivekimab Started During Hospitalization For Type 1 Myocardial Infarction

  • Investigator: Imran Arif
  • Posted Date: May 15, 2025
  • Type of Study: Drug

• Furthering Our Understanding Of Bipolar Disorder

  • Investigator: Caleb Adler
  • Posted Date: May 9, 2025
  • Type of Study: Observational/Survey

• Video-Based Smartphone-Assisted Bradykinesia Assessment In Parkinson’S Disease

  • Investigator: Luca Marsili
  • Posted Date: May 9, 2025
  • Type of Study: Observational/Survey

• A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing The Efficacy, Safety And Tolerability Of Three Doses Of Orally Administered Bms-986368, A Faah/Mgll Inhibitor, For The Treatment Of Spasticity In Participants W

  • Investigator: Shahla Hosseini
  • Posted Date: Apr 30, 2025
  • Type of Study: Drug

• Is "No News Is Good News" Enough? A Thematic Analysis Exploring Clinical Reasoning Assessment In Pediatric Residency Programs

  • Investigator: Jimmy Bowen
  • Posted Date: Apr 29, 2025
  • Type of Study: Observational/Survey

• This Study Aims To Investigate Toripalimab With Chemotherapy In Participants With Nasopharyngeal Cancer.

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 28, 2025
  • Type of Study: Drug

• A Randomized, Open-Label, Parallel-Group, Non-Inferiority Study Comparing Efficacy, Safety, And Tolerability Of Remibrutinib After Switching From Ocrelizumab In Participants Living With Relapsing Multiple Sclerosis, Followed By Open-Label Treatment With R

  • Investigator: Aram Zabeti
  • Posted Date: Apr 28, 2025
  • Type of Study: Drug

• D-Dimer For Vte

  • Investigator: Gregory Fermann
  • Posted Date: Apr 28, 2025
  • Type of Study: Observational/Survey

• Phase III Trial Of Single Fraction Stereotactic Radiosurgery (Srs) Versus Fractionated Srs (Fsrs) For Intact Brain Metastases

  • Investigator: Kyle Wang
  • Posted Date: Apr 28, 2025
  • Type of Study: Observational/Survey

• A Phase 3 Randomized Double-Blind Study Of Adjuvant Pembrolizumab With Or Without V940 In Participants With Resectable Stage II To IIIb (N2) Nsclc Not Achieving Pcr After Receiving Neoadjuvant Pembrolizumab With Platinum-Based Doublet Chemotherapy (Interp

  • Investigator: Christopher Lemmon
  • Posted Date: Apr 16, 2025
  • Type of Study: Drug

• Rasolute 302: A Phase 3 Multicenter, Open-Label, Randomized Study Of Daraxonrasib (Rmc-6236) Versus Investigator's Choice Of Standard Of Care Therapy In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)

  • Investigator: Davendra Sohal
  • Posted Date: Apr 15, 2025
  • Type of Study: Drug

• Testing The Addition Of The Drug Bmx-001, A Radioprotector, Or A Placebo To The Usual Chemoradiation Therapy For Patients With Head And Neck Cancer

  • Investigator: Vinita Takiar
  • Posted Date: Apr 14, 2025
  • Type of Study: Drug

• Testing The Addition Of An Anti-Cancer Drug, Abemaciclib, To The Usual Chemotherapy Treatment (5-Fluorouracil) For Metastatic, Refractory Colorectal Cancer

  • Investigator: Davendra Sohal
  • Posted Date: Apr 14, 2025
  • Type of Study: Drug

• Humanitarian Use Device Ibv Valve Placement

  • Investigator: Patrick Kosciuk
  • Posted Date: Apr 2, 2025
  • Type of Study: Device

• Para Athlete Research For Wellness, Injury Prevention, And Sports Medicine Excellence (Para-Wise) Registry

  • Investigator: Victoria Heasley
  • Posted Date: Apr 2, 2025
  • Type of Study: Observational/Survey

• This Is A Dose-Escalation And Dose-Expansion Phase 1/2A Trial To Evaluate The Safety And Tolerability Of Db-1305/Bnt325 In Subjects With Advanced Solid Tumors.

  • Investigator: Trisha Wise-Draper
  • Posted Date: Mar 31, 2025
  • Type of Study: Drug

• Optimizing Her2 Testing In Oncologic Pathology: A Comparative Analysis Of Ihc, Ish, And Ngs

  • Investigator: Rachel Jug
  • Posted Date: Mar 19, 2025
  • Type of Study: Observational/Survey

• Multi-Arm Multi-Stage Adaptive Platform Trial (Apt) For The Acute Treatment Of Traumatic Brain Injury

  • Investigator: Laura Ngwenya
  • Posted Date: Mar 19, 2025
  • Type of Study: Drug

• A Phase 3, Randomized, Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Sacituzumab Tirumotecan Maintenance Treatment With Or Without Bevacizumab Versus Standard Of Care After Second-Line Platinum-Based Doublet Chemotherapy In Particip

  • Investigator: Thomas Herzog
  • Posted Date: Mar 17, 2025
  • Type of Study: Drug

• A Study Of Car T-Cell Therapy And Its Effects On Handwriting And Coordination

  • Investigator: Luca Marsili
  • Posted Date: Mar 10, 2025
  • Type of Study: Observational/Survey

• A Phase 1A/1B Trial Of Ly3962673 In Participants With Kras G12d-Mutant Solid Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Mar 10, 2025
  • Type of Study: Drug

• Adult Add/Adhd And Dental Avoidance

  • Investigator: Eric Holmes
  • Posted Date: Mar 6, 2025
  • Type of Study: Observational/Survey

• Level

  • Investigator: Juliane Vierecke
  • Posted Date: Mar 5, 2025
  • Type of Study: Drug

• Librexia Acs

  • Investigator: Naseer Khan
  • Posted Date: Mar 5, 2025
  • Type of Study: Drug

• Proactive Hf II

  • Investigator: Vladimir Cotarlan
  • Posted Date: Mar 5, 2025
  • Type of Study: Device

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel Group Study Of Vhb937 In Amyotrophic Lateral Sclerosis (Als) Over 40 Weeks Followed By An Open-Label Extension (Astrals)

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2025
  • Type of Study: Drug

• Responder Hf

  • Investigator: Rishi Sukhija
  • Posted Date: Mar 5, 2025
  • Type of Study: Device

• A Post-Authorization Study To Assess Long-Term Safety In Patients With Pompe Disease Treated With Avalglucosidase Alfa

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2025
  • Type of Study: Observational/Survey

• Swog 1823

  • Investigator: Robert Franklin
  • Posted Date: Mar 5, 2025
  • Type of Study: Observational/Survey

• Balance D Hf

  • Investigator: Juliane Vierecke
  • Posted Date: Mar 5, 2025
  • Type of Study: Drug

• Weight Loss After Orthognathic Surgery

  • Investigator: James Phero
  • Posted Date: Mar 5, 2025
  • Type of Study: Observational/Survey

• Recharge Revascularization Choices Among Underrepresented Groups Evaluation

  • Investigator: Cristiano Spadaccio
  • Posted Date: Feb 24, 2025
  • Type of Study: Observational/Survey

• A Phase 1/2, Open-Label, Multi-Center Study Of The Safety, Tolerability, And Efficacy Of Gim-531 As A Single Agent And In Combination With Anti-Pd-1 In Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Feb 21, 2025
  • Type of Study: Drug

• React-Af

  • Investigator: Richard Becker
  • Posted Date: Feb 20, 2025
  • Type of Study: Device

• Librexia-Stroke

  • Investigator: Matthew Flaherty
  • Posted Date: Feb 19, 2025
  • Type of Study: Drug

• Ask-Chf (Phosphatase Inhibition By Intracoronary Gene Tx In Non- Ischemic Nyha III Heart Failure)

  • Investigator: Vladimir Cotarlan
  • Posted Date: Feb 18, 2025
  • Type of Study: Drug

• Fortifi-Hn01: A Study Of Ficerafusp Alfa (Bca101) Or Placebo In Combination With Pembrolizumab In First-Line Pd-L1-Pos, R Or M Hnscc (Fortifi-Hn01)

  • Investigator: Trisha Wise-Draper
  • Posted Date: Feb 10, 2025
  • Type of Study: Drug

• Study Assessing Activity Of Intravenous (Iv) Etentamig Monotherapy Versus Standard Available Therapies In Adult Participants With Relapsed Or Refractory Multiple Myeloma (Cervino)

  • Investigator: Edward Faber
  • Posted Date: Feb 10, 2025
  • Type of Study: Drug

• A Study To Learn About The Study Medicine Pf-07934040 When Given Alone Or With Other Anti-Cancer Therapies In People With Advanced Solid Tumors That Have A Genetic Mutation.

  • Investigator: Davendra Sohal
  • Posted Date: Feb 10, 2025
  • Type of Study: Drug

• Managed Access Program (Map) Cohort Treatment Plan Clou064a2002m To Provide Access To Remibrutinib For Adult Patients With Chronic Spontaneous Urticaria (Csu)

  • Investigator: Yashu Dhamija
  • Posted Date: Jan 27, 2025
  • Type of Study: Drug

• The Purpose Of This Study Is To Learn About The Effects Of A New Study Drug, Called Sgr-3515 That May Be A Treatment For Advanced Solid Tumors.

  • Investigator: Amanda Jackson
  • Posted Date: Jan 21, 2025
  • Type of Study: Drug

• Assessment Of Aviation Worker Attitudes Toward Safety

  • Investigator: Yevgen Nazarenko
  • Posted Date: Jan 13, 2025
  • Type of Study: Observational/Survey

• A Phase 1 Open-Label Study To Evaluate The Pharmacokinetics And Safety Of K-808 (Pemafibrate) In Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis And Without Cirrhosis

  • Investigator: Khurram Bari
  • Posted Date: Jan 13, 2025
  • Type of Study: Drug

• A Study To Determine The Efficacy And Safety In Patients With Moderate To Severe Hidradenitis Suppurativa

  • Investigator: Alan Fleischer
  • Posted Date: Jan 13, 2025
  • Type of Study: Drug

• Coaching Conversation At The Transitio To Residency

  • Investigator: Matthew Kelleher
  • Posted Date: Jan 13, 2025
  • Type of Study: Observational/Survey

• Optimizing Cns Dha Delivery In Elderly Adults At Risk For Dementia

  • Investigator: Robert Mcnamara
  • Posted Date: Jan 7, 2025
  • Type of Study: Drug

• A Phase 3, Multicenter, 3-Week Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy, Safety And Pharmacokinetic Study Of Evening Dosed Methylphenidate Hydrochloride Extended-Release Capsules (Hld200) In Children Aged 4 To 5 Ye

  • Investigator: Melissa Delbello
  • Posted Date: Jan 7, 2025
  • Type of Study: Drug

• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Lumateperone For The Treatment Of Major Depressive Episodes (Mdes) Associated With Bipolar I Or Bipolar II Disorder (Bipolar Depression) In Pediatric

  • Investigator: Melissa Delbello
  • Posted Date: Jan 7, 2025
  • Type of Study: Drug

• An Open-Label, Multicenter Trial To Assess The Safety And Tolerability Of Lumateperone In The Treatment Of Pediatric Patients With Schizophrenia Or Bipolar Disorder

  • Investigator: Melissa Delbello
  • Posted Date: Jan 7, 2025
  • Type of Study: Drug

• State Of Ohio Adversity And Resilience (Soar) Deep Phenotyping Study (Brain Health Study)

  • Investigator: Melissa Delbello
  • Posted Date: Jan 7, 2025
  • Type of Study: Observational/Survey

• A Study Of Dostarlimab Vs Placebo After Chemoradiation In Adult Participants With Locally Advanced Unresected Head And Neck Squamous Cell Carcinoma (Jade)

  • Investigator: Christopher Lemmon
  • Posted Date: Jan 6, 2025
  • Type of Study: Drug

• A Phase 1 Multiple Dose Study To Evaluate The Safety And Tolerability Of Xmab819 In Subjects With Relapsed Or Refractory Clear Cell Renal Cell Carcinoma

  • Investigator: Robert Franklin
  • Posted Date: Jan 6, 2025
  • Type of Study: Drug

• Analysis Of Fat Graft Injections Used In Treatment Of Glottal Insufficiency

  • Investigator: Greg Dion
  • Posted Date: Dec 5, 2024
  • Type of Study: Observational/Survey

• Modern: An Integrated Phase 2/3 And Phase 3 Trial Of Mrd-Based Optimization Of Adjuvant Therapy In Urothelial Cancer

  • Investigator: Robert Franklin
  • Posted Date: Nov 26, 2024
  • Type of Study: Drug

• Temperature-Controlled Radiofrequency Ablation In Patients With Allergic And Nonallergic Chronic Rhinitis (Bioklear)

  • Investigator: Katie Phillips
  • Posted Date: Nov 26, 2024
  • Type of Study: Device

• Predictors And Outcomes Of Alcohol Relapse Following Liver Transplantation For Alcohol-Associated Liver Disease

  • Investigator: Khurram Bari
  • Posted Date: Nov 19, 2024
  • Type of Study: Observational/Survey

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy And Safety Study Of Povorcitinib In Participants With Prurigo Nodularis

  • Investigator: Alan Fleischer
  • Posted Date: Nov 18, 2024
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind, Multicenter Study Of Mk-1084 In Combination With Pembrolizumab Compared With Pembrolizumab Plus Placebo As Firstline Treatment Of Participants With Kras G12c-Mutant, Metastatic Nsclc With Pd-L1 Tps =50%

  • Investigator: Christopher Lemmon
  • Posted Date: Nov 12, 2024
  • Type of Study: Drug

• A Randomized, Open-Label Study Evaluating The Efficacy And Safety Of Cemacabtagene Ansegedleucel In Participants With Minimal Residual Disease After Response To First Line Therapy For Large B-Cell Lymphoma (Alpha3)

  • Investigator: Tahir Latif
  • Posted Date: Nov 12, 2024
  • Type of Study: Drug

• Tempus Phoenix Hnscc Study: A Longitudinal Multi-Omic Biomarker Profiling Study Of Patients With Head & Neck Squamous Cell Carcinoma (Hnscc)

  • Investigator: Christopher Lemmon
  • Posted Date: Nov 12, 2024
  • Type of Study: Observational/Survey

• A Phase 3 Randomized, Double-Blind, Placebo- Controlled, Global Study To Evaluate The Efficacy And Safety Of Intravenous Aoc 1001 For The Treatment Of Myotonic Dystrophy Type 1

  • Investigator: Hani Kushlaf
  • Posted Date: Nov 7, 2024
  • Type of Study: Drug

• A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating The Long-Term Treatment Of Bimekizumab In Study Participants With Moderate To Severe Hidradenitis Suppurativa

  • Investigator: Alan Fleischer
  • Posted Date: Nov 6, 2024
  • Type of Study: Drug

• A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating The Long-Term Treatment Of Bimekizumab In Study Participants With Moderate To Severe Hidradenitis Suppurativa

  • Investigator: Alan Fleischer
  • Posted Date: Nov 6, 2024
  • Type of Study: Drug

• A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multi-Site, Parallel-Group, Dose-Finding Trial To Evaluate The Efficacy And Safety Of Different Doses Of Subcutaneously Administered Leo 138559 In Adult Subjects With Moderate-To-Severe Atopic Derm

  • Investigator: Alan Fleischer
  • Posted Date: Nov 6, 2024
  • Type of Study: Drug

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Barzolvolimab In Patients With Prurigo Nodularis

  • Investigator: Alan Fleischer
  • Posted Date: Nov 6, 2024
  • Type of Study: Drug

• Development And Validation Of An Ancillary Diagnostic Test For Mycosis Fungoides (Signal-Mf)

  • Investigator: Alan Fleischer
  • Posted Date: Nov 6, 2024
  • Type of Study: Device

• A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating The Long-Term Treatment Of Bimekizumab In Study Participants With Moderate To Severe Hidradenitis Suppurativa

  • Investigator: Debra Breneman
  • Posted Date: Nov 5, 2024
  • Type of Study: Drug

• A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Biib059 In Participants With Active Subacute Cutaneous Lupus Erythematosus And/Or Chronic Cutaneous

  • Investigator: Debra Breneman
  • Posted Date: Nov 5, 2024
  • Type of Study: Drug

• A Prospective, Multicenter, Long-Term Study To Assess The Safety And Efficacy Of Nemolizumab (Cd14152) In Subjects With Moderate-To-Severe Atopic Dermatitis

  • Investigator: Alan Fleischer
  • Posted Date: Nov 5, 2024
  • Type of Study: Drug

• Mindmed

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 4, 2024
  • Type of Study: Drug

• Precise

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 4, 2024
  • Type of Study: Drug

• Uc Ibd Clinical Data Registry

  • Investigator: Anita Afzali
  • Posted Date: Oct 15, 2024
  • Type of Study: Observational/Survey

• Nci Cervical Cancer ‘Last Mile’ Initiative ‘Self-Collection For Hpv Testing To Improve Cervical Cancer Prevention’ (Ship) Trial

  • Investigator: Leeya Pinder
  • Posted Date: Oct 14, 2024
  • Type of Study: Device

• Evaluating The Mechanical And Histological Properties Of Deep Vein Thrombi In Vivo For Diagnostic Clinical Benefit.

  • Investigator: Wisam Beauti
  • Posted Date: Oct 14, 2024
  • Type of Study: Observational/Survey

• Venetoclax For The Treatment Of Patients With Relapsed Hairy Cell Leukemia

  • Investigator: Zulfa Omer
  • Posted Date: Oct 7, 2024
  • Type of Study: Drug

• Study Of Chs-114 In Participants With Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Oct 7, 2024
  • Type of Study: Drug

• A Phase 3 Study To Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma Patients

  • Investigator: Christopher Lemmon
  • Posted Date: Oct 7, 2024
  • Type of Study: Drug

• Tak Vdz-4066

  • Investigator: Anita Afzali
  • Posted Date: Sep 24, 2024
  • Type of Study: Observational/Survey

• Transition To Residency Course Needs Assessment - Resident Perspective

  • Investigator: Amy Guiot
  • Posted Date: Sep 23, 2024
  • Type of Study: Observational/Survey

• A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study To Evaluate Efficacy And Safety And The Maintenance Of Effect Of 20-Mg Seltorexant As Adjunctive Therapy To Antidepressants In Adult And Elderly Patients With Major Depressive Disor

  • Investigator: Caleb Adler
  • Posted Date: Sep 9, 2024
  • Type of Study: Drug

• Testing The Addition Of Ipatasertib To Usual Chemotherapy And Radiation For Head And Neck Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: Sep 9, 2024
  • Type of Study: Drug

• Metabol-Ich

  • Investigator: Stacie Demel
  • Posted Date: Sep 6, 2024
  • Type of Study: Observational/Survey

• Clinician Knowledge, Attitudes, Practices (Kap) Concerning Closed-Loop Control Of Mechanical Ventilation

  • Investigator: Brian Ring
  • Posted Date: Sep 5, 2024
  • Type of Study: Observational/Survey

• Cardiothoracic Surgery Outcomes

  • Investigator: Cristiano Spadaccio
  • Posted Date: Sep 5, 2024
  • Type of Study: Observational/Survey

• A Phase 3, Randomized, Double-Blind, Placebo- And Active-Comparator-Controlled Clinical Study Of Adjuvant V940 (Mrna-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab In Participants With Resected Stage II, IIIa, IIIb (N2) Non-Small Cell

  • Investigator: Jennifer Leddon
  • Posted Date: Sep 3, 2024
  • Type of Study: Drug

• Post-Mastectomy Recovery: A Randomized Clinical Trial Comparing Preoperative Pecs-II Blocks With Intraoperative Pectoral Blocks

  • Investigator: Alicia Heelan
  • Posted Date: Aug 28, 2024
  • Type of Study: Drug

• Electrical Impedance Tomography And Mechanical Ventilation Liberation In Tracheostomized Subjects : Physiological Assessment

  • Investigator: Brian Ring
  • Posted Date: Aug 12, 2024
  • Type of Study: Observational/Survey

• Tracheoesophageal High-Speed Imaging;

  • Investigator: Greg Dion
  • Posted Date: Aug 8, 2024
  • Type of Study: Observational/Survey

• Study Of Ras(On) Inhibitors In Patients With Gastrointestinal Solid Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Aug 6, 2024
  • Type of Study: Drug

• Testing The Addition Of An Anti-Cancer Drug, Sndx-5613, To The Standard Chemotherapy Treatment (Daunorubicin And Cytarabine) For Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes In Npm1 Or Mll/?Kmt2a Gene

  • Investigator: Emily Curran
  • Posted Date: Aug 6, 2024
  • Type of Study: Drug

• Clubhouse De-Escalation Study

  • Investigator: Delaney Schrenk
  • Posted Date: Aug 1, 2024
  • Type of Study: Observational/Survey

• Social Determinants Of Health- Medical Student Experience With And Proposed Interventions To Fill Curricular Gaps

  • Investigator: Corinne Lehmann
  • Posted Date: Jul 23, 2024
  • Type of Study: Observational/Survey

• Norm: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated In A Randomized Phase 2 Trial With Either Rituximab Or Mosunetuzumab

  • Investigator: Zulfa Omer
  • Posted Date: Jul 18, 2024
  • Type of Study: Drug

• Eus Guided Liver Biopsy Left Vs Right Lobe

  • Investigator: Mubarak Sayyar
  • Posted Date: Jul 18, 2024
  • Type of Study: Device

• Evaluating Efficacy When Transitioning From A Current Disease Modifying Therapy 9Dmt) To Ublituximab (Enhance)

  • Investigator: Lawrence Goldstick
  • Posted Date: Jul 15, 2024
  • Type of Study: Drug

• Optimice-Pcr: De-Escalation Of Therapy In Early-Stage Tnbc Patients Who Achieve Pcr After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

  • Investigator: Kerri Mcgovern
  • Posted Date: Jul 5, 2024
  • Type of Study: Drug

• Image Detection Of Impaired Microcirculatory Reperfusion (Id Imr)

  • Investigator: Yasmin Aziz
  • Posted Date: Jun 17, 2024
  • Type of Study: Observational/Survey

• Vx-147 For Adults With Apol1-Mediated Proteinuric Kidney Disease

  • Investigator: Prakash Gudsoorkar
  • Posted Date: Jun 13, 2024
  • Type of Study: Drug

• A Phase II Trial Of Durvalumab With Gemcitabine And Cisplatin As Neoadjuvant Therapy For High-Risk Resectable Intrahepatic Cholangiocarcinoma

  • Investigator: Davendra Sohal
  • Posted Date: Jun 7, 2024
  • Type of Study: Drug

• Cognitive Training For Cancer Related Cognitive Impairment In Breast Cancer Survivors

  • Investigator: Sarah Sittenfeld
  • Posted Date: Jun 5, 2024
  • Type of Study: Observational/Survey

• A Phase 2 Study Of Lattice Radiotherapy For Dose-Escalated Palliation Of Bulky Tumors

  • Investigator: Andrew Frankart
  • Posted Date: Jun 3, 2024
  • Type of Study: Device

• Representative Utility Values For The Modified Rankin (Ruler)

  • Investigator: Paul Wechsler
  • Posted Date: Jun 3, 2024
  • Type of Study: Observational/Survey

• Testing The Addition Of An Anti-Cancer Drug, Zen003694, To The Usual Chemotherapy Treatment (Capecitabine) For Metastatic Or Unresectable Cancers

  • Investigator: Davendra Sohal
  • Posted Date: May 17, 2024
  • Type of Study: Drug

• Study To Evaluate Adverse Events And Change In Disease Activity In Adult Participants With B-Cell Malignancies Receiving Oral Abbv-525 Tablets

  • Investigator: Zulfa Omer
  • Posted Date: May 14, 2024
  • Type of Study: Drug

• Establishing Reference Values

  • Investigator: Brittany Krekeler
  • Posted Date: May 9, 2024
  • Type of Study: Device

• An Informatics Approach To Study The Associations Between Glp-1 Receptor Agonist Medications And Endoscopy And Anesthesia Outcomes

  • Investigator: Inuk Zandvakili
  • Posted Date: May 7, 2024
  • Type of Study: Observational/Survey

• Explainable Artificial Intelligence For Psychiatry Consultation For Medically Hospitalized Patients

  • Investigator: David Karol
  • Posted Date: May 4, 2024
  • Type of Study: Observational/Survey

• Bion-1301 For Adults With Iga Nephropathy (The Beyond Study)

  • Investigator: Manish Anand
  • Posted Date: May 2, 2024
  • Type of Study: Drug

• Legend Study: Eg-70 In Nmibc Patients Bcg-Unresponsive And High-Risk Nmibc Incompletely Treated With Bcg Or Bcg-Naïve

  • Investigator: Alberto Martini
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Phase III Trial Of Docetaxel Vs. Docetaxel And Radium-223 For Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

  • Investigator: Robert Franklin
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Randomized Phase II Study Of Cho(E)P Vs Cc-486-Cho(E)P Vs Duvelisib-Cho(E)P In Previously Untreated Cd30 Negative Peripheral T-Cell Lymphomas

  • Investigator: Tahir Latif
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Study Of Df9001 In Patients With Advanced Solid Tumors

  • Investigator: Jennifer Leddon
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Evaluation Tracking Project: A Prospective Chart Review Of Patients Treated With Radiation Therapy

  • Investigator: Luke Pater
  • Posted Date: Apr 26, 2024
  • Type of Study: Observational/Survey

• A Phase 1/?2 Study Of Mrtx0902 In Solid Tumors With Mutations In The Kras Mapk Pathway

  • Investigator: Davendra Sohal
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Amivantamab In Adenoid Cystic Carcinoma

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Phase 1, First In Human Study Of Ds-1055A In Subjects With Relapsed Or Refractory Locally Advanced Or Metastatic Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Study Of Acr-368 In Ovarian Carcinoma, Endometrial Adenocarcinoma, And Urothelial Carcinoma

  • Investigator: Caroline Billingsley
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Phase 2 Open-Label, Multicenter Study To Evaluate Efficacy And Safety Of Zn-C3 In Adult Women With Recurrent Or Persistent Uterine Serous Carcinoma

  • Investigator: Caroline Billingsley
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Phase 1/2A, Multicenter, Open-Label, First In Human Study To Assess The Safety, Tolerability, Pharmacokinetics, And Preliminary Antitumor Activity Of Db-1311 In Subjects With Advanced/Metastatic Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Phase 1/2, Open-Label Study Of Pd-1 Knockout Tumor-Infiltrating Lymphocytes (Iov-4001) In Participants With Unresectable Or Metastatic Melanoma Or Stage III Or Iv Non-Small-Cell Lung Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Reframe-O1: A Study To Investigate The Efficacy And Safety Of Luveltamab Tazevibulin Versus Investigator's Choice (Ic) Chemotherapy In Women With Ovarian Cancer (Including Fallopian Tube Or Primary Peritoneal Cancers) Expressing Folr1

  • Investigator: Amanda Jackson
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Phase 2 Basket Trial Of Nab-Sirolimus In Patients With Malignant Solid Tumors With Pathogenic Alterations In Tsc1/?Tsc2 Genes (Precision 1)

  • Investigator: Davendra Sohal
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Phase 1, First-In-Human, Dose-Finding And Expansion Study To Evaluate Xmab®808 In Combination With Pembrolizumab In Advanced Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Safety And Efficacy Of Krt-232 In Combination With Acalabrutinib In Subjects With R/?R Dlbcl Or R/?R Cll

  • Investigator: John Byrd
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Nrg Lu-008: Phase III Prospective Randomized Trial Of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer

  • Investigator: Emily Daugherty
  • Posted Date: Apr 26, 2024
  • Type of Study: Device

• A Trial To Find Out How Safe Regn7075 Is And How Well It Works In Combination With Cemiplimab For Adult Participants With Advanced Cancers (Combine-Egfr-1)

  • Investigator: Davendra Sohal
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Phase 2 Multi-Center Pharmacodynamic Study Of Tvb-2640 In Kras Mutant Non-Small Cell Lung Carcinomas

  • Investigator: Jennifer Leddon
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Bxq-350 In Newly Diagnosed Metastatic Colorectal Carcinoma (Asist)

  • Investigator: Davendra Sohal
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• Randomized Phase II Trial Of Postoperative Adjuvant Capecitabine And Temozolomide Versus Observation In High-Risk Pancreatic Neuroendocrine Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Apr 26, 2024
  • Type of Study: Drug

• A Study Of The Efficacy And Safety Of Adjuvant Autogene Cevumeran Plus Atezolizumab And Mfolfirinox Versus Mfolfirinox Alone In Participants With Resected Pancreatic Ductal Adenocarcinoma (Imcode003)

  • Investigator: Davendra Sohal
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• A Phase II Evaluation Of The Safety And Efficacy Of Mirvetuximab Soravtansine (Imgn853) In Women With Folate Receptor-? Positive Persistent Or Recurrent Endometrial Cance

  • Investigator: Amanda Jackson
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• Redel Trial: Reduced Elective Nodal Dose For Anal Cancer Toxicity Mitigation

  • Investigator: Jordan Kharofa
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial Of Selinexor In Maintenance Therapy After Systemic Therapy For Patients With P53 Wild-Type, Advanced Or Recurrent Endometrial Carcinoma

  • Investigator: Amanda Jackson
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• Kowa Pbc K-808-2.01

  • Investigator: Khurram Bari
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• A Phase 2 Exploratory, Multicenter, Open-Label Trial To Determine The Safety And Preliminary Clinical Activity Of Gen1046 In Combination With Anticancer Agents In Subjects With Advanced Endometrial Cancer

  • Investigator: Amanda Jackson
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• An Open-Label, Randomized Phase 3 Study Of Mk-2870 As A Single Agent And In Combination With Pembrolizumab Versus Treatment Of Physician's Choice In Participants With Hr+/Her2- Unresectable Locally Advanced Or Metastatic Breast Cancer

  • Investigator: Amanda Jackson
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• A Phase 1/2 Study Investigating The Safety And Efficacy Of Autologous Tac T Cells In Subjects With Unresectable, Locally Advanced Or Metastatic Claudin 18.2+ Solid Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• Ide196 (Darovasertib) In Combination With Crizotinib Versus Investigator’S Choice Of Treatment As First-Line Therapy In Hla-A2 Negative Metastatic Uveal Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Apr 25, 2024
  • Type of Study: Drug

• A Novel Wearable System For Monitoring And Alerting For Seizures And Cardiorespiratory Dysfunctions

  • Investigator: Michael Privitera
  • Posted Date: Apr 24, 2024
  • Type of Study: Device

• Efficacy, Safety And Tolerability Of Bhv-7000 In Subjects With Refractory Focal Onset Epilepsy- Rise 2

  • Investigator: Michael Privitera
  • Posted Date: Apr 24, 2024
  • Type of Study: Drug

• Dental Infection Extreme Learning Machine

  • Investigator: Eric Holmes
  • Posted Date: Apr 23, 2024
  • Type of Study: Observational/Survey

• Study Of Hearing Loss Using Mri

  • Investigator: Daniel Sun
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Spinal Ropivacaine For Cesarean Sectionm

  • Investigator: Andrea Girnius
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Efficacy And Safety Of Zanubrutinib Vs Tacrolimus In Patients With Primary Membranous Nephropathy

  • Investigator: Manish Anand
  • Posted Date: Apr 22, 2024
  • Type of Study: Drug

• Investigating Unique Brain Biomarkers In Elite Athletes

  • Investigator: Brady Williamson
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Repeated Assessment Of Survivors In Intracerebral Hemorrhage Study (Reassess Ich)

  • Investigator: Matthew Flaherty
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Society Of Obstetric Anesthesia And Perinatology Registry For General Anesthesia Use During C Section

  • Investigator: Andrea Girnius
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Does Low-Dose Ketamine Administration Around The Time Of Surgery Reduce Chronic Pain After Mastectomy?

  • Investigator: Brian Vaughan
  • Posted Date: Apr 22, 2024
  • Type of Study: Drug

• A Phase 3 Trial Of Prgn-2012 For The Treatment Of Recurrent Respiratory Papillomatosis In Adult Patients

  • Investigator: Aaron Friedman
  • Posted Date: Apr 22, 2024
  • Type of Study: Drug

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study To Assess The Efficacy And Safety Of Verekitug (Upb-101) In Participants With Chronic Rhinosinusitis With Nasal Polyps On A Background Of Nasal Corticosteroids (Vibrant)

  • Investigator: Ahmad Sedaghat
  • Posted Date: Apr 22, 2024
  • Type of Study: Drug

• C Section Iv Supplementation

  • Investigator: Andrea Girnius
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Impact Of Lingual Endurance Exercise On Rehabilitation Of Swallowing Impairments After Lschemic Stroke

  • Investigator: Brittany Krekeler
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Awareness Of Pimping Term In Non-Physician Healthcare Providers

  • Investigator: Demetrio Sharp Dimitri
  • Posted Date: Apr 20, 2024
  • Type of Study: Observational/Survey

• Improving Listening With Cochlear Implantation

  • Investigator: Daniel Sun
  • Posted Date: Apr 19, 2024
  • Type of Study: Observational/Survey

• Self-Reported Mental Health In Adults With Cerebral Palsy

  • Investigator: Jensine Clark
  • Posted Date: Apr 19, 2024
  • Type of Study: Observational/Survey

• Posibil6eskd: Cardiovascular Outcome Study Of Csl300 (Clazakizumab) In Subjects With End Stage Kidney Disease On Dialysis

  • Investigator: Jwalant Modi
  • Posted Date: Apr 19, 2024
  • Type of Study: Drug

• Timing Of Antenatal Steroid Administration And Effects On The Newborn Infant: A Retrospective Study

  • Investigator: Vivek Narendran
  • Posted Date: Apr 19, 2024
  • Type of Study: Observational/Survey

• A Prospective, Multicenter, Randomized, Open-Label, Phase 2, Parallel, Dose Ranging Multidose Study Of Thrombosomes® Vs Liquid Stored Platelets (Lsp) In Bleeding Thrombocytopenic Patients

  • Investigator: Jose Cancelas
  • Posted Date: Apr 18, 2024
  • Type of Study: Drug

• Student-Alumni Network Pilot

  • Investigator: Delaney Schrenk
  • Posted Date: Apr 18, 2024
  • Type of Study: Observational/Survey

• Comfort And Effectiveness Of Using Vortexpap To Control Obstructive Sleep Apnea

  • Investigator: Liran Oren
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Cancer Related Cognitive Impairment (Crci) And Its Relationship To Specific Types Of Changes In Thinking And Other Medical Conditions

  • Investigator: Rhonna Shatz
  • Posted Date: Apr 18, 2024
  • Type of Study: Observational/Survey

• Verification Protocol For 1.042 G/Cm3 Shelf For Apc-60

  • Investigator: Jose Cancelas
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Predictive Value Of High-Risk Human Papilloma Virus For Cervical Dysplasia

  • Investigator: Rachel Jug
  • Posted Date: Apr 18, 2024
  • Type of Study: Observational/Survey

• Share Your Experience With Diabetes And Continuous Glucose Monitors (Device On Arm/Belly That Measures Blood Sugar)

  • Investigator: Michelle Knopp
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Evaluation For The Safety Of Frontlineodptm In A Multidose Randomized Cohort Study Compared With Pf24

  • Investigator: Caroline Alquist
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Collection Of Blood Products Acquired By The Trima Accel System Into Non-Dehp Disposable Tubing Sets For Laboratory Evaluations

  • Investigator: Jose Cancelas
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Use Of Blood Products Acquired By Trima Accel System Or Whole Blood Collections For Laboratory Evaluations

  • Investigator: Jose Cancelas
  • Posted Date: Apr 18, 2024
  • Type of Study: Device

• Dural Suturing Instrumentation Simulator

  • Investigator: Jonathan Forbes
  • Posted Date: Oct 31, 2023
  • Type of Study: Observational/Survey

• Novartis Ianalumab Injections For Lupus Nephritis

  • Investigator: Manish Anand
  • Posted Date: Aug 2, 2023
  • Type of Study: Drug

• A5415 A Limited-Center, Prospective, Double-Blind, Placebo-Controlled Study To Evaluate The Effects Of Cenicriviroc Mesylate On Arterial Inflammation In People Living With Hiv

  • Investigator: Moises Huaman
  • Posted Date: Apr 25, 2023
  • Type of Study: Drug

• Social Media Impact On Lived Experience Of Peripartum Women

  • Investigator: Jyoti Sachdeva
  • Posted Date: Apr 19, 2023
  • Type of Study: Observational/Survey

• Are Health Care Providers Confident In Guiding And Providing Care To Adaptive Athletes?

  • Investigator: Victoria Heasley
  • Posted Date: Mar 27, 2023
  • Type of Study: Observational/Survey

• Biomarkers Of Disease Progression In Progressive Supranuclear Palsy

  • Investigator: Alberto Espay
  • Posted Date: Mar 13, 2023
  • Type of Study: Observational/Survey

• Nightingale: Clinical Utility Of Management Of Patients With Ct And Ldct Identified Pulmonary Nodules Using The Percepta Nasal Swab Classifier – With Familiarization.

  • Investigator: Christopher Radchenko
  • Posted Date: Mar 12, 2023
  • Type of Study: Device

• Flash Radiotherapy For The Treatment Of Symptomatic Bone Metastases In The Thorax (Fast-02)

  • Investigator: John Breneman
  • Posted Date: Feb 27, 2023
  • Type of Study: Device

• Utility Of An Epic Emr Shortcut For A Consolidated Drug History In Patients Admitted With Drug Induced Cutaneous Eruptions.

  • Investigator: Sweta Subhadarshani
  • Posted Date: Feb 27, 2023
  • Type of Study: Observational/Survey

• Cell Culture Of Patient-Derived Primary Vocal Fold

  • Investigator: Greg Dion
  • Posted Date: Feb 20, 2023
  • Type of Study: Observational/Survey

• Site For Fleck Ct-155-R-001 Digital Therapeutic (App) Study

  • Investigator: David Fleck
  • Posted Date: Feb 17, 2023
  • Type of Study: Device

• Changes In Novel Plasma Secretory Proteins Among Patients Undergoing Transcatheter Mitral Valve Intervention And Impact On Outcome

  • Investigator: Demetrio Sharp Dimitri
  • Posted Date: Feb 16, 2023
  • Type of Study: Observational/Survey

• Doxycycline For Emphysema In People Living With Hiv (The Depth Trial)

  • Investigator: Carl Fichtenbaum
  • Posted Date: Feb 16, 2023
  • Type of Study: Drug

• Occupation-Related Stress Of Home Healthcare Workers And Ambient Pollution Exposures

  • Investigator: Thomas Gerding
  • Posted Date: Feb 14, 2023
  • Type of Study: Observational/Survey

• Swallowing Disparities In Oropharyngeal Squamous Cell Carcinoma (Opscc)

  • Investigator: David Rule
  • Posted Date: Jan 31, 2023
  • Type of Study: Observational/Survey

• Disparities And Equity In Childhood Cardiovascular Exposures And Alzheimer’S Dementia: The I3c Decade Study

  • Investigator: Achala Vagal
  • Posted Date: Jan 30, 2023
  • Type of Study: Observational/Survey

• Comparative Microbial Ecology In Adult Laryngotracheal And Subglottic Stenosis

  • Investigator: Greg Dion
  • Posted Date: Jan 23, 2023
  • Type of Study: Observational/Survey

• Somatostatin Level In Cystic Fibrosis

  • Investigator: Jason Winnick
  • Posted Date: Dec 20, 2022
  • Type of Study: Observational/Survey

• A Study To Evaluate The Safety And Effectiveness Of Cotadutide Given By Subcutaneous Injection In Adult Patients With Non-Alcoholic Steatohepatitis (Nash) With Scarring But Not Cirrhosis.

  • Investigator: Kenneth Sherman
  • Posted Date: Dec 14, 2022
  • Type of Study: Drug

• The Child Bipolar Disorder Network (Cbn): A Collaborative Treatment Study Of Youth With Or At High Risk For Bipolar Disorder

  • Investigator: Luis Patino Duran
  • Posted Date: Dec 12, 2022
  • Type of Study: Observational/Survey

• The Effects Of Tefillin On Markers Of Heart Function And Inflammation

  • Investigator: Jack Rubinstein
  • Posted Date: Dec 12, 2022
  • Type of Study: Device

• Tracheotomy Assist Device

  • Investigator: Greg Dion
  • Posted Date: Dec 12, 2022
  • Type of Study: Observational/Survey

• A Phase III, Multicentre, Randomised, Double-Blind, Controlled Study To Investigate The Efficacy, Safety, And Tolerability Of Two Administrations Of Comp360 In Participants With Treatment-Resistant Depression

  • Investigator: Fabiano Nery
  • Posted Date: Dec 12, 2022
  • Type of Study: Drug

• Sofia Aspiration System As The First Line Technique

  • Investigator: Charles Prestigiacomo
  • Posted Date: Oct 18, 2022
  • Type of Study: Device

• Development And Validation Of The Unified Tremor Rating Scale (Utrs)

  • Investigator: Luca Marsili
  • Posted Date: Oct 18, 2022
  • Type of Study: Observational/Survey

• Pro-Active: Comparing The Effectiveness Of Prophylactic Swallow Intervention For Patients Receiving Radiotherapy For Head And Neck Cancer

  • Investigator: Brittany Krekeler
  • Posted Date: Sep 19, 2022
  • Type of Study: Observational/Survey

• Research 101

  • Investigator: Jason Blackard
  • Posted Date: Sep 11, 2022
  • Type of Study: Observational/Survey

• Patterns Of Social Media Use By Autistic Communities

  • Investigator: Al Lutwak
  • Posted Date: Aug 30, 2022
  • Type of Study: Observational/Survey

• Treatment Of Hrs-Aki As A Complication Of Cirrhosis With Ascites

  • Investigator: Khurram Bari
  • Posted Date: Aug 30, 2022
  • Type of Study: Drug

• Development And Validation Of A Machine Learning Model For Automated Workplace-Based Assessment Of Resident Clinical Reasoning Documentation

  • Investigator: Danielle Weber
  • Posted Date: Aug 23, 2022
  • Type of Study: Observational/Survey

• Effects Of Lingual Endurance Exercise On Rehabilitation Of Swallowing Impairment After

  • Investigator: Brittany Krekeler
  • Posted Date: Aug 11, 2022
  • Type of Study: Device

• The Helping Children With Loss Instrument (Hcwl-I): Instrument Development And Validation For Construct Validity Of The Treatment

  • Investigator: Rachael Nolan
  • Posted Date: Jul 28, 2022
  • Type of Study: Observational/Survey

• The Influence Of Popular Media On Biases Of Potential Care Providers Toward Nonspeaking Autistic People

  • Investigator: Al Lutwak
  • Posted Date: Jul 25, 2022
  • Type of Study: Observational/Survey

• Association Between Lingual Function And Oropharyngeal Swallow Physiology

  • Investigator: Brittany Krekeler
  • Posted Date: Jul 12, 2022
  • Type of Study: Observational/Survey

• Propofol And Difficult Sedation - Retrospective Study

  • Investigator: Michael Grau
  • Posted Date: Jun 24, 2022
  • Type of Study: Observational/Survey

• A Survey-Based Study To Assess Physician And Perinatal Women's Perspectives On Perinatal Mental Health Care Availability And Accessibility Across The State Of Ohio

  • Investigator: Jyoti Sachdeva
  • Posted Date: Jun 14, 2022
  • Type of Study: Observational/Survey

• Mino-Scd: Minocycline In Neurocognitive Outcomes – Sickle Cell Disease

  • Investigator: Kristine Karkoska
  • Posted Date: Jun 7, 2022
  • Type of Study: Drug

• Post-Prandial Diarrhea And Dermatographism: A Case Series

  • Investigator: Yashu Dhamija
  • Posted Date: Jun 6, 2022
  • Type of Study: Observational/Survey

• Stem Cell Transplant In Mcl With Mutated Tp53

  • Investigator: Bryan Hambley
  • Posted Date: May 6, 2022
  • Type of Study: Observational/Survey

• Healthy Aging And Alzheimer's Disease In Epilepsy

  • Investigator: Russell Sawyer
  • Posted Date: Apr 25, 2022
  • Type of Study: Observational/Survey

• Enlighten 2: Evaluate The Efficacy And Safety Of Lyr-210

  • Investigator: Ahmad Sedaghat
  • Posted Date: Apr 25, 2022
  • Type of Study: Device

• Study Of Brain Signals While Making Decisions And Resolving Conflicts

  • Investigator: Ishita Basu
  • Posted Date: Apr 13, 2022
  • Type of Study: Device

• Project Pics: Innovation, Collaboration, And Community Impact

  • Investigator: Rachael Nolan
  • Posted Date: Apr 4, 2022
  • Type of Study: Observational/Survey

• Optune Lua For Malignant Pleural Mesothelioma

  • Investigator: Emily Daugherty
  • Posted Date: Feb 25, 2022
  • Type of Study: Device

• Evaluation Of Complicated Living Grief In Head And Neck Cancer Patients And Survivors

  • Investigator: Rachael Nolan
  • Posted Date: Feb 15, 2022
  • Type of Study: Observational/Survey

• Non-Invasive Skin Imaging For Exploratory Evaluation Of Serum Bilirubin Levels

  • Investigator: Khurram Bari
  • Posted Date: Feb 8, 2022
  • Type of Study: Device

• Long-Term Study Evaluating The Long-Term Safety And Tolerability Of Once Daily Centanafadine Capsules In Children And Adolescents With Attention-Deficit/Hyperactivity Disorder

  • Investigator: Luis Patino Duran
  • Posted Date: Feb 7, 2022
  • Type of Study: Drug

• The Outcomes Of Holmium Laser Enucleation Of Prostate In Benign Prostatic Hyperplasia Patients With Voiding And Storage Lower Urinary Tract Symptoms: A Comparative Study.

  • Investigator: Mostafa Mostafa
  • Posted Date: Jan 31, 2022
  • Type of Study: Observational/Survey

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Attack Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oral Ubrogepant In The Acute Treatment Of Migraine With Or Without Aura In Children And Adole

  • Investigator: Luis Patino Duran
  • Posted Date: Jan 19, 2022
  • Type of Study: Drug

• Risk Factors For Wound Complications After Veno-Arterial Extra Corporeal Membrane Oxygenation Decannulation

  • Investigator: Jose Oyama Moura Leite
  • Posted Date: Jan 10, 2022
  • Type of Study: Observational/Survey

• Speckled Immunofluorescence Pattern In Heart Transplant Biopsies And Association With Anti-Thymocyte Globulin

  • Investigator: Jackson Walker
  • Posted Date: Jan 8, 2022
  • Type of Study: Observational/Survey

• Portopulmonary Hypertension Biobank

  • Investigator: Arun Jose
  • Posted Date: Jan 7, 2022
  • Type of Study: Observational/Survey

• Nemolizumab In Subjects With Prurigo Nodularis

  • Investigator: Alan Fleischer
  • Posted Date: Jan 3, 2022
  • Type of Study: Drug

• C4471001 A Two-Part, Phase 1A/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety And Efficacy Of Pf 07284890 (Arry 461) In Participants With Braf V600 Mutant Solid Tumors With And Without Brain Involvement

  • Investigator: Trisha Wise-Draper
  • Posted Date: Dec 15, 2021
  • Type of Study: Drug

• Virtual Residency Interview Backgrounds Survey

  • Investigator: Dennis Vaysburg
  • Posted Date: Dec 6, 2021
  • Type of Study: Observational/Survey

• Relationship Between Milestones And Epas Crosswalk Study

  • Investigator: Benjamin Kinnear
  • Posted Date: Dec 6, 2021
  • Type of Study: Observational/Survey

• Nrg-Br007 A Phase III Clinical Trial Evaluating De-Escalation Of Breast Radiation For Conservative Treatment Of Stage I, Hormone Sensitive, Her-2 Negative, Oncotype Recurrence Score Less Than Or Equal To 18 Breast Cancer

  • Investigator: Teresa Meier
  • Posted Date: Nov 16, 2021
  • Type of Study: Drug

• Efficacy And Safety Of Pozelimab And Cemdisiran Combination Therapy In Patients With Symptomatic Generalized Myasthenia Gravis

  • Investigator: Hani Kushlaf
  • Posted Date: Nov 12, 2021
  • Type of Study: Drug

• Dupilumab Versus Omalizumab

  • Investigator: Ahmad Sedaghat
  • Posted Date: Nov 8, 2021
  • Type of Study: Drug

• The Nucleus® Hybrid™ L24 Implant System New Enrollment Study

  • Investigator: Ravi Samy
  • Posted Date: Nov 2, 2021
  • Type of Study: Device

• A Dynamic Functional Immune Assay To Evaluate The Immune Response Of A Patient With Deep Space Neck Infections (Dsni)

  • Investigator: Deepak Krishnan
  • Posted Date: Oct 27, 2021
  • Type of Study: Observational/Survey

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing The Efficacy And Safety Of Tafasitamab Plus Lenalidomide In Addition To R-Chop Versus R-Chop In Previously Untreated, High-Intermediate And High-Risk Patients With Newly-

  • Investigator: Tahir Latif
  • Posted Date: Oct 26, 2021
  • Type of Study: Drug

• A Randomized Phase III Study Of Immune Checkpoint Inhibition With Chemotherapy In Treatment-Naïve Metastatic Anal Cancer Patients

  • Investigator: Davendra Sohal
  • Posted Date: Oct 26, 2021
  • Type of Study: Drug

• Prospective Evaluation Of Carvedilol In Prevention Of Cardiac Toxicity In Patients With Metastatic Her-2+ Breast Cancer, Phase III

  • Investigator: Mahmoud Charif
  • Posted Date: Oct 21, 2021
  • Type of Study: Drug

• A Pilot Study Of Pembrolizumab And Lenvatinib Combination Therapy In Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma

  • Investigator: Davendra Sohal
  • Posted Date: Oct 19, 2021
  • Type of Study: Drug

• A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing The Efficacy And Safety Of Capivasertib+Abiraterone Versus Placebo+Abiraterone As Treatment For Patients With Denovo Metastatic Hormone-Sensitive Prostate Cancer Characterised By Pte

  • Investigator: Shuchi Gulati
  • Posted Date: Oct 19, 2021
  • Type of Study: Drug

• Focus Group Study To Understand Coronary Revascularization In Dialysis Patients.

  • Investigator: Silvi Shah
  • Posted Date: Oct 18, 2021
  • Type of Study: Observational/Survey

• Cancer In The Ed

  • Investigator: Richard Ryan
  • Posted Date: Oct 4, 2021
  • Type of Study: Observational/Survey

• Implantable Marker Devices In Breast Surgery, To Localize A Lesion That Cannot Be Felt

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: Oct 4, 2021
  • Type of Study: Observational/Survey

• Medical Students And General Surgery

  • Investigator: Ralph Quillin
  • Posted Date: Sep 26, 2021
  • Type of Study: Observational/Survey

• Resensation: Restoring Sensation With Breast Reconstruction After Mastectomy

  • Investigator: Ryan Gobble
  • Posted Date: Sep 22, 2021
  • Type of Study: Device

• A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study Of Risankizumab Compared To Ustekinumab For The Treatment Of Adult Subjects With Moderate To Severe Crohn's Disease Who Have Failed Anti-Tnf Therapy

  • Investigator: Loren Brook
  • Posted Date: Sep 21, 2021
  • Type of Study: Drug

• Academic Research Services Satisfaction Survey

  • Investigator: Eric Smith
  • Posted Date: Sep 20, 2021
  • Type of Study: Observational/Survey

• Botox For The Prevention Of Migraine In Patients With Episodic Migraine

  • Investigator: Lesley Arnold
  • Posted Date: Sep 20, 2021
  • Type of Study: Drug

• Molecular Assessment And Profiling Of Liver Transplant Recipients: The Maple Study

  • Investigator: Shimul Shah
  • Posted Date: Sep 20, 2021
  • Type of Study: Device

• Lp-168-Us-I01 A Phase I, Multicenter, Open-Label, Dose-Escalation Study To Evaluate Safety, Tolerability, Pharmacokinetics, And Clinical Activity Of Orally Administered Lp-168 In Subjects With Relapsed Or Refractory B-Cell Malignancies

  • Investigator: John Byrd
  • Posted Date: Aug 24, 2021
  • Type of Study: Drug

• Trendelenburg Motion Assessment

  • Investigator: Kermit Davis
  • Posted Date: Aug 23, 2021
  • Type of Study: Observational/Survey

• Anxiety And Baseline Knowledge Of Colposcopy Study

  • Investigator: Rhea Eubanks
  • Posted Date: Aug 17, 2021
  • Type of Study: Observational/Survey

• Avb500-Oc-004 A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study Of Avb-S6-500 In Combination With Paclitaxel In Patients With Platinum-Resistant Recurrent Ovarian Cancer

  • Investigator: Thomas Herzog
  • Posted Date: Aug 3, 2021
  • Type of Study: Drug

• A221805 Duloxetine To Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II To Phase III Study

  • Investigator: Jordan Kharofa
  • Posted Date: Aug 3, 2021
  • Type of Study: Drug

• Rpl-003-19 An Open-Label, Multicenter, Phase 1B Study Of Rp1 In Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma (Cscc)

  • Investigator: Trisha Wise-Draper
  • Posted Date: Aug 3, 2021
  • Type of Study: Drug

• Rpl-001-16 An Open-Label, Multicenter, Phase 1/2 Study Of Rp1 As A Single Agent And In Combination With Pd1 Blockade In Patients With Solid Tumors

  • Investigator: Trisha Wise-Draper
  • Posted Date: Aug 3, 2021
  • Type of Study: Drug

• Patient Characteristics Associated With Episodes Of Agitation Or Aggression

  • Investigator: Kristina Reinstatler
  • Posted Date: Aug 2, 2021
  • Type of Study: Observational/Survey

• A Multi-Center Clinical Trial To Evaluate The Efficacy And Safety Of Biib059 In Adult Participants With Active Systemic Lupus Erythematosus

  • Investigator: Michael Luggen
  • Posted Date: Jul 29, 2021
  • Type of Study: Drug

• Uc Heart Bank

  • Investigator: Dylan Steen
  • Posted Date: Jul 21, 2021
  • Type of Study: Observational/Survey

• Resident Non Technical Skills And Trauma Bay Outcomes

  • Investigator: Lane Frasier
  • Posted Date: Jul 20, 2021
  • Type of Study: Observational/Survey

• Tapur Targeted Agent And Profiling Utilization Registry (Tapur) Study

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jul 19, 2021
  • Type of Study: Drug

• Incb 00928-105 A Phase 1/2, Open-Label, Multicenter Study Of Incb000928 Administered As A Monotherapy In Participants With Anemia Due To Myelodysplastic Syndromes Or Multiple Myeloma

  • Investigator: Emily Curran
  • Posted Date: Jul 13, 2021
  • Type of Study: Drug

• Obstetrical Post-Partum Hemorrhage Simulation

  • Investigator: Nicole King
  • Posted Date: Jul 13, 2021
  • Type of Study: Observational/Survey

• D18-11141 Phase 3 Randomized Trial Of Dfp-10917 Vs Non-Intensive Reinduction (Lodac, Azacitidine, Decitabine, Venetoclax Combination Regimens) Or Intensive Reinduction (High & Intermediate Dose Cytarabine Regimens) For Acute Myelogenous Leukemia Patients

  • Investigator: Emily Curran
  • Posted Date: Jul 13, 2021
  • Type of Study: Drug

• The Frequency Of Mismatch Between Hemoglobin A1c And Other Measures Of Glycemic Control In An Urban Academic General Medicine Clinic: The Role Of Fructosamine And Continuous Glucose Monitoring In Primary Care

  • Investigator: Jared Friedman
  • Posted Date: Jul 13, 2021
  • Type of Study: Observational/Survey

• Lp-118-Us-I01 A Phase 1/1B Study Evaluating The Safety, Pharmacokinetics, And Preliminary Efficacy Of Lp-118 In Subjects With Relapsed Or Refractory Hematological Malignancies

  • Investigator: Emily Curran
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• Rtx-321-01 A Phase 1 Study Of Rtx-321 For The Treatment Of Patients With Advanced Malignancies Associated With Human Papillomavirus-16 Infection

  • Investigator: Amanda Jackson
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• Ea8183 A Phase III Double Blinded Study Of Early Intervention After Radical Prostatectomy With Androgen Deprivation Therapy With Or Without Darolutamide Vs. Placebo In Men At Highest Risk Of Prostate Cancer Metastasis By Genomic Stratification (Eradicate)

  • Investigator: Abhinav Sidana
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• Ca224-104 A Phase 2 Randomized Double-Blind Study Of Relatlimab Plus Nivolumab In Combination With Chemotherapy Vs. Nivolumab In Combination With Chemotherapy As First Line Treatment For Participants With Stage Iv Or Recurrent Non-Small Cell Lung Cancer (

  • Investigator: Jennifer Leddon
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• Nrg-Gu008 Randomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone And Apalutamide And Advanced Imaging Into Salvage Treatment For Patients With Node-Positive Prostate Cancer After Radical Prostatectomy

  • Investigator: Timothy Struve
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• Ide196-001 A Phase 1/2 Study Of Ide196 In Patients With Solid Tumors Harboring Gnaq/11 Mutations Or Prkc Fusions

  • Investigator: Trisha Wise-Draper
  • Posted Date: Jul 6, 2021
  • Type of Study: Drug

• A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study To Evaluate The Efficacy And Safety Of Seltorexant 20 Mg As Adjunctive Therapy To Antidepressants In Adult And Elderly Patients With Major Depressive Disorder With Insomnia

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Jun 22, 2021
  • Type of Study: Drug

• Phase 1/2, Two-Part, Open-Label Dose-Escalation And Double-Blind, Placebo-Controlled Dose-Expansion Study With An Open-Label Extension To Evaluate The Safety And Efficacy Of Ata188 In Subjects With Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Jun 22, 2021
  • Type of Study: Drug

• Predictors Of Chronic Pain And New Persistent Opioid Use After Lung Resection

  • Investigator: Robert Van Haren
  • Posted Date: Jun 22, 2021
  • Type of Study: Observational/Survey

• Hiv Prevention Study

  • Investigator: Moises Huaman
  • Posted Date: Jun 17, 2021
  • Type of Study: Drug

• Applicants To General Surgery Residency Support Integration Of A Virtual Interview Format

  • Investigator: Dennis Vaysburg
  • Posted Date: Jun 14, 2021
  • Type of Study: Observational/Survey

• Tongue And Hyoid Movement Using Ultrasound In Normal And Abnormal Swallows

  • Investigator: Rebecca Howell
  • Posted Date: Jun 14, 2021
  • Type of Study: Observational/Survey

• Machine Learning-Based Automated Alerts For Epilepsy Surgery Candidates

  • Investigator: Benjamin Wissel
  • Posted Date: Jun 14, 2021
  • Type of Study: Observational/Survey

• Perfusion Imaging In Incomplete Left Bundle Branch Block

  • Investigator: Myron Gerson
  • Posted Date: May 22, 2021
  • Type of Study: Observational/Survey

• Ea6192- A Phase II Study Of Biomarker Driven Early Discontinuation Of Anti-Pd-1 Therapy In Patients With Advanced Melanoma (Pet-Stop)

  • Investigator: Rekha Chaudhary
  • Posted Date: May 20, 2021
  • Type of Study: Drug

• Ea5182- Osimertinib With Or Without Bevacizumab As Initial Treatment For Patients With Egfr-Mutant Lung Cancer

  • Investigator: Christopher Lemmon
  • Posted Date: May 13, 2021
  • Type of Study: Drug

• S1712- A Randomized Phase II Study Of Ruxolitinib (Nsc-752295) In Combination With Bcr-Abl Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia (Cml) Patients With Molecular Evidence Of Disease

  • Investigator: Emily Curran
  • Posted Date: May 13, 2021
  • Type of Study: Drug

• Survey Of United States Attending Surgeons On Audio Video Recording Practices

  • Investigator: Lane Frasier
  • Posted Date: May 7, 2021
  • Type of Study: Observational/Survey

• S1905- A Phase II Study Of Akr1c3-Activated Prodrug Obi-3424 (Obi-3424) In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-All)

  • Investigator: Emily Curran
  • Posted Date: May 7, 2021
  • Type of Study: Drug

• Uccc-Gi-20-02

  • Investigator: Davendra Sohal
  • Posted Date: May 6, 2021
  • Type of Study: Drug

• S1931-Phase III Trial Of Immunotherapy-Based Combination Therapy With Or Without Cytoreductive Nephrectomy For Metastatic Renal Cell Carcinoma (Probe Trial)

  • Investigator: Robert Franklin
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Mk-7902-009-A Phase 2, Randomized, Open-Label Three-Arm Clinical Study To Evaluate The Safety And Efficacy Of Lenvatinib (E7080/Mk-7902) In Combination With Pembrolizumab (Mk-3475) Versus Standard Of Care Chemotherapy And Lenvatinib Monotherapy In Partici

  • Investigator: Christopher Lemmon
  • Posted Date: May 5, 2021
  • Type of Study: Drug

• Ppmi 2.0 Clinical -Establishing A Deeply Phenotyped Pd Cohort

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• Trial Of Parkinson’S And Zoledronic Acid

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• A Dose Selection Trial Of Light Therapy For Impaired Sleep In Parkinson’S Disease

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Device

• The Dystonia Coalition Natural History And Biospecimen Repository For Isolated Dystonias (Dcp)

  • Investigator: Abhimanyu Mahajan
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• Iov-Lun-202- A Phase 2 Multicenter Study Of Autologous Tumor Infiltrating Lymphocytes (Ln-145) In Patients With Metastatic Non-Small-Cell Lung Cancer

  • Investigator: Jennifer Leddon
  • Posted Date: Apr 28, 2021
  • Type of Study: Drug

• Ca209-73L- A Phase 3, Randomized, Open Label Study To Compare Nivolumab Plus Concurrent Chemoradiotherapy (Ccrt) Followed By Nivolumab Plus Ipilimumab Or Nivolumab Plus Ccrt Followed By Nivolumab Vs Ccrt Followed By Durvalumab In Previously Untreated, Loc

  • Investigator: Emily Daugherty
  • Posted Date: Apr 28, 2021
  • Type of Study: Drug

• Ecog Multiple Myeloma Equate Trial (Eaa181)

  • Investigator: Bryan Hambley
  • Posted Date: Apr 20, 2021
  • Type of Study: Drug

• Outcomes Of A First Generation Support Network For Undergraduate Pre-Professional Students

  • Investigator: Shawn Adkins
  • Posted Date: Mar 22, 2021
  • Type of Study: Observational/Survey

• An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab

  • Investigator: Lawrence Goldstick
  • Posted Date: Mar 19, 2021
  • Type of Study: Drug

• Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Feb 15, 2021
  • Type of Study: Drug

• Sunbeam (Systems Biology Of Early Atopy): A Mother- Infant Cohort Study

  • Investigator: Robert Rossi
  • Posted Date: Feb 12, 2021
  • Type of Study: Observational/Survey

• The Role Of The Circadian System In Binge Eating Disorder

  • Investigator: Francisco Romo-Nava
  • Posted Date: Feb 4, 2021
  • Type of Study: Device & Drug

• A Phase 3, Open-Label, 1-Year Study Of The Safety, Tolerability, And Need For Re-Treatment With Sage-217 In Adult Subjects With Major Depressive Disorder

  • Investigator: Caleb Adler
  • Posted Date: Jan 25, 2021
  • Type of Study: Drug

• Effects Of Plasma Exchange On Adolescent And Adult Patients With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (Pandas)

  • Investigator: Caroline Alquist
  • Posted Date: Jan 21, 2021
  • Type of Study: Observational/Survey

• Social Media In The Virtual Interview Residency Cycle

  • Investigator: Jaime Lewis
  • Posted Date: Jan 20, 2021
  • Type of Study: Observational/Survey

• R1216- Randomized Phase II/III Trial Of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, Or Cisplatin-Atezolizumab In Pathologic High-Risk Squamous Cell Cancer Of The Head And Neck

  • Investigator: Sara Medek
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• A041501- A Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell All

  • Investigator: Emily Curran
  • Posted Date: Jan 18, 2021
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind Study Comparing The Efficacy And Safety Of Sage-217 Plus An Antidepressant Versus Placebo Plus An Antidepressant In Adults With Major Depressive Disorder

  • Investigator: Caleb Adler
  • Posted Date: Jan 6, 2021
  • Type of Study: Drug

• A Trial Of Transplanting Hepatitis C Kidneys Into Hepatitis C Negative Kidney Recipients

  • Investigator: Ervin Steve Woodle
  • Posted Date: Jan 5, 2021
  • Type of Study: Drug

• Pre0905- Randomized Trial Of Gilteritinib Vs Midostaurin In Flt3 Mutated Acute Myeloid Leukemia (Aml)

  • Investigator: Emily Curran
  • Posted Date: Dec 19, 2020
  • Type of Study: Drug

• Morab-202-G000-201- A Phase II Study Of Ipilimumab, Cabozantinib, And Nivolumab In Rare Genitourinary Cancers (Iconic)

  • Investigator: Amanda Jackson
  • Posted Date: Dec 17, 2020
  • Type of Study: Drug

• Epigenetic Signature Of Prenatal Opioid Exposure

  • Investigator: Brittany Smith
  • Posted Date: Dec 14, 2020
  • Type of Study: Observational/Survey

• A041703- A Phase II Study Of Inotuzumab Ozogamicin Followed By Blinatumomab For Ph-Negative Cd22-Positive B-Lineage Acute Lymphoblastic Leukemia In Newly Diagnosed Older Adults Or Adults With Relapsed Or Refractory Diseas

  • Investigator: Emily Curran
  • Posted Date: Nov 28, 2020
  • Type of Study: Drug

• S1820- A Randomized Trial Of The Altering Intake, Managing Symptoms Intervention For Bowel Dysfunction In Rectal Cancer Survivors Compared To A Healthy Living Education Control: A Feasibility And Preliminary Efficacy Study (Aims-Rc)

  • Investigator: Jordan Kharofa
  • Posted Date: Nov 28, 2020
  • Type of Study: Observational/Survey

• Mk-3475-937- A Phase 3 Double-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy Of Pembrolizumab (Mk-3475) Versus Placebo As Adjuvant Therapy In Participants With Hepatocellular Carcinoma And Complete Radiological Response After Surgical Resectio

  • Investigator: Davendra Sohal
  • Posted Date: Nov 24, 2020
  • Type of Study: Drug

• Lae002int2001- An Open-Label Randomized Active-Controlled Phase II Clinical Study To Assess The Efficacy And Safety Of Afuresertib Plus Paclitaxel Versus Paclitaxel In Patients With Platinum-Resistant Ovarian Cancer

  • Investigator: Thomas Herzog
  • Posted Date: Nov 24, 2020
  • Type of Study: Drug

• Use Of Benralizumab For Patients With Moderate To Severe Atopic Dermatitis Despite Treatment With Topical Medications

  • Investigator: Debra Breneman
  • Posted Date: Nov 17, 2020
  • Type of Study: Drug

• Ea3132- Phase II Randomized Trial Of Radiotherapy With Or Without Cisplatin For Surgically Resected Squamous Cell Carcinoma Of The Head And Neck (Scchn) With Tp53 Sequencing

  • Investigator: Trisha Wise-Draper
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Gog-3031- A Phase 3, Randomized, Double-Blind, Multicenter Study Of Dostarlimab (Tsr-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel In Patients With Recurrent Or Primary Advanced Endometrial Cancer (Ruby)

  • Investigator: Caroline Billingsley
  • Posted Date: Oct 26, 2020
  • Type of Study: Drug

• Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Oct 23, 2020
  • Type of Study: Drug

• Voice Quality Analysis In Recurrent Respiratory Papillomatosis (Rrp)

  • Investigator: Aaron Friedman
  • Posted Date: Oct 11, 2020
  • Type of Study: Observational/Survey

• Ea6141- Phase II/III Trial Of Nivolumab, Ipilimumab, And Gm-Csf In Patients With Advanced Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: Oct 5, 2020
  • Type of Study: Drug

• Optimal Timing Of Direct Acting Antivirals In Hepatitis C-Associated Hepatocellular Carcinoma

  • Investigator: Shimul Shah
  • Posted Date: Oct 5, 2020
  • Type of Study: Observational/Survey

• Nrg Lu-007: The Raptor Trial For Extensive Stage Small Cell Lung Cancer; Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy For Es-Sclc

  • Investigator: Emily Daugherty
  • Posted Date: Sep 28, 2020
  • Type of Study: Device

• Law Enforcement Officer Opioid Exposure

  • Investigator: Kermit Davis
  • Posted Date: Sep 28, 2020
  • Type of Study: Observational/Survey

• Optimizing Training In Severe Post-Stroke Walking Impairment

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Quantifying The Role Of Sensory Systems Processing In Post-Stroke Walking Recovery

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Obstetrical Complications Among Women Who Attended A Crisis Pregnancy Center

  • Investigator: Priya Gursahaney
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Equity Impact Of Covid-19 In Medical Education

  • Investigator: Heather Christensen
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Study In Parkinson's Disease Of Exercise Phase 3 Clinical Trial: Sparx3

  • Investigator: Alberto Espay
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Alliance A071801- Phase III Trial Of Post-Surgical Single Fraction Stereotactic Radiosurgery (Srs) Compared With Fractionated Srs (Fsrs) For Resected Metastatic Brain Disease

  • Investigator: Kyle Wang
  • Posted Date: Sep 11, 2020
  • Type of Study: Observational/Survey

• A 4-Week Study In Subjects Aged 10 To 17 Years With Bipolar I Disorder

  • Investigator: Luis Patino Duran
  • Posted Date: Sep 9, 2020
  • Type of Study: Drug

• Gb002 In Adult Subjects With Pah

  • Investigator: Jean Elwing
  • Posted Date: Sep 8, 2020
  • Type of Study: Drug

• Bms Ca031-002- A Phase 1/2 First-In-Human Study Of Bms-986258 Alone And In Combination With Nivolumab In Advanced Malignant Tumors

  • Investigator: Davendra Sohal
  • Posted Date: Sep 7, 2020
  • Type of Study: Drug

• Apexigen Apx005m-006- A Phase 2 Study Of Apx005m In Combination With Concurrent Chemoradiation As Neoadjuvant Therapy For Resectable Esophageal And Gastroesophageal Junction Cancers

  • Investigator: Davendra Sohal
  • Posted Date: Sep 4, 2020
  • Type of Study: Drug

• Mk7902-012- A Phase 3 Multicenter, Randomized, Double-Blinded, Active-Controlled, Clinical Study To Evaluate The Safety And Efficacy Of Lenvatinib (E7080/Mk-7902) With Pembrolizumab (Mk-3475) In Combination With Transarterial Chemoembolization (Tace) Vers

  • Investigator: Olugbenga Olowokure
  • Posted Date: Sep 4, 2020
  • Type of Study: Drug

• Pathology Of Mast Cell Disease

  • Investigator: Nives Zimmermann
  • Posted Date: Sep 2, 2020
  • Type of Study: Observational/Survey

• Maternal Morbidity After Expectant Management Of Previable Preterm Rupture Of Membranes

  • Investigator: Marianne Dinapoli
  • Posted Date: Sep 1, 2020
  • Type of Study: Observational/Survey

• The Association Of Adverse Childhood Experiences And Social Determinants Of Health On Hiv States And Outcomes

  • Investigator: David Karol
  • Posted Date: Aug 27, 2020
  • Type of Study: Observational/Survey

• Preeclampsia Blood Collection Study

  • Investigator: Emily Defranco
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Barriers And Facilitators To Prevention Of Cov1d-19 In Latinx Families

  • Investigator: Amy Rule
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Maverick Trial: Mri Brain Surveillance Alone Versus Mri Surveillance And Prophylactic Cranial Irradiation (Pci) - A Randomized Phase III Trial In Small-Cell Lung Cancer

  • Investigator: Emily Daugherty
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• A Dynamic Functional Immune Assay To Evaluate The Immune Response Of A Patient With Diabetes And A Foot Infection

  • Investigator: Michael Liette
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Qualitative Assessment Of Patient Perception Of Control And Exacerbation In Crs

  • Investigator: Ahmad Sedaghat
  • Posted Date: Aug 26, 2020
  • Type of Study: Observational/Survey

• Erich-Gene

  • Investigator: Stacie Demel
  • Posted Date: Aug 25, 2020
  • Type of Study: Observational/Survey

• Ecog-Acrin Ea2182- A Randomized Phase II Study Of De-Intensified Chemoradiation For Early- Stage Anal Squamous Cell Carcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: Jul 8, 2020
  • Type of Study: Drug

• Understanding Stress Caused By Covid-19 Pandemic Among Home Healthcare Providers

  • Investigator: Kermit Davis
  • Posted Date: Jun 9, 2020
  • Type of Study: Observational/Survey

• Trailblazer (I5t-Mc-Aaci): Assessment Of Safety, Tolerability, And Efficacy Of Donanemab In Early Symptomatic Alzheimer’S Disease

  • Investigator: Lawrence Goldstick
  • Posted Date: Jun 9, 2020
  • Type of Study: Drug

• Recurrence After Robotic Hysterectomy For Cervical Cancer

  • Investigator: Amanda Jackson
  • Posted Date: Jun 5, 2020
  • Type of Study: Observational/Survey

• Alector Study

  • Investigator: Russell Sawyer
  • Posted Date: May 29, 2020
  • Type of Study: Drug

• Swog S1806 Phase III Randomized Trial Of Concurrent Chemoradiotherapy With Or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer

  • Investigator: Robert Franklin
  • Posted Date: May 22, 2020
  • Type of Study: Drug

• Hyperpolarized 129-Xe Magnetic Resonance Imaging For Lung Disease - Pediatric Asthma

  • Investigator: Nancy Lin
  • Posted Date: Apr 20, 2020
  • Type of Study: Device & Drug

• Ehr-Embedded Decision Support To Prevent Stroke In Patients With Af

  • Investigator: Mark Eckman
  • Posted Date: Apr 1, 2020
  • Type of Study: Observational/Survey

• Cincinnati Cohort Biomarkers Program

  • Investigator: Alberto Espay
  • Posted Date: Mar 16, 2020
  • Type of Study: Observational/Survey

• Ea4181- A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab And High Dose Cytarabine (Br/Cr) 2.) Bendamustine, Rituximab, High Dose Cytarabine And Acalabrutinib (Br/Cr-A), And 3.) Bendamustine, Rituximab And Acalabrutinib (Br-A) In Pat

  • Investigator: Tahir Latif
  • Posted Date: Mar 11, 2020
  • Type of Study: Observational/Survey

• Fviia For Acute Hemorrhagic Stroke Administered At Earliest Time (Fastest) Trial

  • Investigator: Kyle Walsh
  • Posted Date: Mar 9, 2020
  • Type of Study: Drug

• Nrg-Gy018- A Phase III Randomized, Placebo-Controlled Study Of Pembrolizumab (Mk-3475, Nsc #776864) In Addition To Paclitaxel And Carboplatin For Measurable Stage III Or Iva, Stage Ivb Or Recurrent Endometrial Cancerchemoradiation Plus Atezolizumab

  • Investigator: Amanda Jackson
  • Posted Date: Mar 6, 2020
  • Type of Study: Drug

• Ea4151-A Randomized Phase III Trial Of Consolidation With Autologous Hematopoietic Cell Transplantation Followed By Maintenance Rituximab Vs. Maintenance Rituximab Alone For Patients With Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Com

  • Investigator: Tahir Latif
  • Posted Date: Mar 4, 2020
  • Type of Study: Drug

• J2g-Mc-Jzjb- A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Loxo-292 To Physicians Choice Of Cabozantinib Or Vandetanib In Patients With Progressive, Advanced, Kinase Inhibitor Naïve, Ret-Mutant Medullary Thyroid Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: Mar 4, 2020
  • Type of Study: Drug

• Alliance A021703- Randomized Double-Blind Phase III Trial Of Vitamin D3 Supplementation In Patients With Previously Untreated Metastatic Colorectal Cancer

  • Investigator: Tahir Latif
  • Posted Date: Feb 27, 2020
  • Type of Study: Drug

• Nrg-Gy022- Assessment Of Carboplatin Clearance Predictors: A Pk Study On Nci-Sponsored Clinical Trials Or Standard Of Care Treatments Using Carboplatin

  • Investigator: Trisha Wise-Draper
  • Posted Date: Feb 27, 2020
  • Type of Study: Observational/Survey

• Pathophysiology Of Medically Managed Inflammatory Sinonasal Disease

  • Investigator: Ahmad Sedaghat
  • Posted Date: Feb 6, 2020
  • Type of Study: Observational/Survey

• Nrg Lu-005: A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab Immunotherapy In Limited Stage Small Cell Lung Cancer (Ls-Sclc)

  • Investigator: Emily Daugherty
  • Posted Date: Feb 5, 2020
  • Type of Study: Drug

• This Study Will Look At The Safety Of Sodium Benzoate, And At How Well It Works In Improving Symptoms Of Schizophrenia When Added To Current Medication

  • Investigator: Caleb Adler
  • Posted Date: Jan 28, 2020
  • Type of Study: Drug

• Prospective Study Tracking Chronic Rhinosinusitis Symptoms On Phone App

  • Investigator: Katie Phillips
  • Posted Date: Jan 24, 2020
  • Type of Study: Observational/Survey

• Effect Of Fasting On Insulin-Induced Hypoglycemia Counterregulation In Individuals With Type 1 Diabetes

  • Investigator: Jason Winnick
  • Posted Date: Jan 23, 2020
  • Type of Study: Drug

• Neuroscience Retrospective Chart Review

  • Investigator: Eva Mistry
  • Posted Date: Jan 23, 2020
  • Type of Study: Observational/Survey

• Study Designed To Evaluate The Long-Term Safety And Efficacy Of Study Drug (Spd503) In Kids With Attention-Deficit/Hyperactivity Disorder

  • Investigator: Melissa Delbello
  • Posted Date: Jan 14, 2020
  • Type of Study: Drug

• Gender Differences, Defect Reversibility, And Imaging Position: Importance For Diagnosis Of Coronary Artery Disease Using A Cadmium-Zinc-Telluride Nuclear Cardiology Camera

  • Investigator: Myron Gerson
  • Posted Date: Dec 24, 2019
  • Type of Study: Device

• Biologics In Allergic Disease: Biologics For Asthma

  • Investigator: Jonathan Bernstein
  • Posted Date: Dec 7, 2019
  • Type of Study: Observational/Survey

• Bariatric Surgery Improving Surgical Outcomes, Our Experience And Future Direction

  • Investigator: Michael Johnston
  • Posted Date: Dec 5, 2019
  • Type of Study: Observational/Survey

• Child Study For Tourette’S Disorder

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child Study For Major Depressive Disorder

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child And Adolescent Generalized Anxiety Disorder Study

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Adults Struggling With Anxiety In The Form Of One Or More Of The Following Diagnoses: Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Anxiety Disorder And/Or Panic Disorder.

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Child Study For The Treatment Of Anxiety Disorders.

  • Investigator: Jeffrey Strawn
  • Posted Date: Nov 22, 2019
  • Type of Study: Drug

• Adolescent Schizophrenia Study

  • Investigator: Luis Patino Duran
  • Posted Date: Nov 21, 2019
  • Type of Study: Drug

• Long-Term Antipsychotic Pediatric Safety Trial (Laps)

  • Investigator: Luis Patino Duran
  • Posted Date: Nov 20, 2019
  • Type of Study: Observational/Survey

• Nrg-Hn005- Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (Ebv) Deoxyribonucleic Acid (Dna)

  • Investigator: Vinita Takiar
  • Posted Date: Nov 7, 2019
  • Type of Study: Drug

• Using Infographic-Based Teaching Techniques To Improve Patient Comprehension And Satisfaction & Acgme Trainees (Residents & Fellows) Satisfaction, A Back To Bedside Proposal

  • Investigator: Andrew Steinmetz
  • Posted Date: Nov 7, 2019
  • Type of Study: Observational/Survey

• A Trial Of Fixed-Dose Brexpiprazole With Sertraline In The Treatment Of Post-Traumatic Stress Disorder

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Oct 30, 2019
  • Type of Study: Drug

• Is Hypotension The Mechanism Behind Cognitive Fluctuations In Parkinson’S Disease Dementia And Dementia With Lewy Bodies?

  • Investigator: Abhimanyu Mahajan
  • Posted Date: Oct 29, 2019
  • Type of Study: Observational/Survey

• Immune Related Adverse Events Following Checkpoint Inhibitors

  • Investigator: Eric Vick
  • Posted Date: Oct 14, 2019
  • Type of Study: Observational/Survey

• A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)

  • Investigator: Lawrence Goldstick
  • Posted Date: Oct 7, 2019
  • Type of Study: Drug

• Reflective Writing In Service Of Patients: The Narrative Medicine Experience Of Categorical Internal Medicine Residents At The University Of Cincinnati Medical Center

  • Investigator: Zeyu Xu
  • Posted Date: Oct 3, 2019
  • Type of Study: Observational/Survey

• S1802- Phase III Randomized Trial Of Standard Systemic Therapy (Sst) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery Or Radiation) Of The Primary Tumor In Metastatic Prostate Cancer

  • Investigator: Robert Franklin
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• Nrg-Gi006- Phase III Randomized Trial Of Proton Beam Therapy (Pbt) Versus Intensity Modulated Photon Radiotherapy (Imrt) For The Treatment Of Esophageal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: Oct 1, 2019
  • Type of Study: Drug

• Ea3163- Phase II Randomized Trial Of Neo-Adjuvant Chemotherapy Followed By Surgery And Post-Operative Radiation Versus Surgery And Post-Operative Radiation For Organ Preservation On T3 And T4a Nasal And Paranasal Sinus Squamous Cell Carcinoma (Npnscc

  • Investigator: Vinita Takiar
  • Posted Date: Oct 1, 2019
  • Type of Study: Observational/Survey

• Increasing Utilization Of Deceased Donor Kidneys: Modeling Outcomes Using Kidneys From Hcv-Infected Donors For Hcv-Uninfected Recipients

  • Investigator: Mark Eckman
  • Posted Date: Sep 5, 2019
  • Type of Study: Observational/Survey

• Efficacy And Safety Of A Medication Taken Daily At Bedtime In Patients With Fibromyalgia

  • Investigator: Lesley Arnold
  • Posted Date: Aug 15, 2019
  • Type of Study: Drug

• Clinical Outcomes Of Thyroid Cancer Patients

  • Investigator: Tammy Holm
  • Posted Date: Jul 30, 2019
  • Type of Study: Observational/Survey

• Clinical Outcomes In Indeterminate Thyroid Nodules

  • Investigator: Tammy Holm
  • Posted Date: Jul 30, 2019
  • Type of Study: Observational/Survey

• Differences Between Trainee And Attending Perceptions On The Educational Value Of Patient Care Activities

  • Investigator: Joshua Kuethe
  • Posted Date: Jul 15, 2019
  • Type of Study: Observational/Survey

• Evaluation Of Fresh Lung Tissue After Surgical Extraction With Clinical Correlations.

  • Investigator: Julian Guitron
  • Posted Date: Jul 15, 2019
  • Type of Study: Observational/Survey

• Prevention Of Hemolytic Anemia Of The Fetus Using A Novel Intravenous Infusion

  • Investigator: Kara Markham
  • Posted Date: Jul 5, 2019
  • Type of Study: Drug

• Prevalence Of Psychiatric Illnesses In Patients Undergoing Oral And Maxillofacial Surgery Procedures In An Outpatient Setting.

  • Investigator: Payal Verma
  • Posted Date: Jul 2, 2019
  • Type of Study: Observational/Survey

• Assessment Of The Use Of Photographs With Skin Biopsies

  • Investigator: Alan Fleischer
  • Posted Date: Jun 27, 2019
  • Type of Study: Observational/Survey

• Nrg Lu-002: Maintenance Systemic Therapy Versus Consolidative Sterotactic Body Radiation Therapy (Sbrt) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial

  • Investigator: Emily Daugherty
  • Posted Date: Jun 17, 2019
  • Type of Study: Drug

• Nrg-Gi003- A Phase III Randomized Trial Of Protons Versus Photons For Hepatocellular Carcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: Jun 17, 2019
  • Type of Study: Observational/Survey

• The Value Of Gut Microbiota In Pulmonary Arterial Hypertension

  • Investigator: Arun Jose
  • Posted Date: Jun 13, 2019
  • Type of Study: Observational/Survey

• A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101

  • Investigator: Brian Moseley
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Clinical Outcomes In Endocrine Disease

  • Investigator: Tammy Holm
  • Posted Date: Jun 11, 2019
  • Type of Study: Observational/Survey

• Ea1151-Tomosynthesis Mammographic Imaging Screening Trial (Tmist)

  • Investigator: Lawrence Sobel
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• General Blood Draw To Help Develop Ways To Break Up Blood Clots

  • Investigator: Christy Holland
  • Posted Date: Jun 6, 2019
  • Type of Study: Device & Drug

• Optimizing Magnetic Resonance Imaging Acquisitions For Brain Imaging

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• Utilization Of Adjuvant Chemotherapy In Patients With Pathologic Complete Response In Rectal Cancer

  • Investigator: Ian Paquette
  • Posted Date: May 29, 2019
  • Type of Study: Observational/Survey

• Ship- A Randomized, Placebo-Controlled Pilot Study Of Sulfasalazine For The Treatment Of Primary Sclerosing Cholangitis

  • Investigator: Kenneth Sherman
  • Posted Date: May 23, 2019
  • Type of Study: Drug

• Subcutaneous Pain Medication To Provide Faster Pain Relief During A Sickle Cell Crisis

  • Investigator: Caroline Freiermuth
  • Posted Date: May 23, 2019
  • Type of Study: Observational/Survey

• Epidemiology Of Subdural Hematomas At The University Of Cincinnati Medical Center

  • Investigator: David Robinson
  • Posted Date: May 22, 2019
  • Type of Study: Observational/Survey

• Trial To Validate Medication Adherence Monitoring Using Facial Recognition And Motion Sensing Technology For Patients Receiving Sublingual Buprenorphi

  • Investigator: T. John Winhusen
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Emergency Contraceptive Study For Females Weighing 176 Pounds Or More Who Have Recently Had Unprotected Intercourse.

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Placebo Controlled Phase 2B/3 Study Of Abt-414 With Concurrent Chemoradiation And Adjuvant Temozolomide In Subjects With Newly Diagnosed

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A151216- Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)

  • Investigator: Emily Daugherty
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Prospective Study Of Magnetic Resonance Imaging (Mri) And Multiparameter Gene Expression Assay In Ductal Carcinoma In Situ (Dcis)

  • Investigator: Neetu Radhakrishnan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing The Effect Of Adding Abiraterone Acetate And Enzalutamide To Metastatic Hormone Refractory Prostate Cancer, When Compared To Enzalutamide Alon

  • Investigator: Nilesh Patil
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Niche Trial: Stroke Recovery Therapy Using Brain Stimulation

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Device

• A Randomized Phase III Trial Of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed By Weekly Paclitaxel With Or Without Carboplat

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating The Use Of Adjuvant Endocrine Therapy +/- One Year Of Everolimus In Patients With H

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study To Evaluate The Safety And Effectiveness Of Evicel? Fibrin Sealant Compared To A Hydrogel Sealant For Sutured Dural Repair

  • Investigator: Norberto Andaluz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase III Study Of Ibrutinib During And Following Autologous Stem Cell Transplantation Versus Placebo In Patients With Relap

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized, Double Blind Trial Of Chemoembolization With Or Without Sorafenib In Unresectable Hepatocellular Carcinoma (Hcc) In Patients W

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab With Or Without Amg 386 In Patients With Recurrent Glioblastoma Or Gliosarcoma.

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A081105- Randomized Study Of Erlotinib Vs Observation In Patients With Completely Resected Epidermal Growth Factor Receptor (Egfr) Mutant Non-Small Cell Lung Cancer (Nscls)

  • Investigator: Christopher Lemmon
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study To Evaluate The Safety And Efficacy Of Estradiol In Combination With Proge

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Post Market Surveillance Study Of The Wingspan? Stent System With Gateway? Percutaneous Transluminal Angioplasty (Pta) Balloon Catheter, Also Known

  • Investigator: Andrew Ringer
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Identification Of A Plasma Proteomic Signature For Lung Cancer

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Patient Assisted Intervention For Neuropathy: Comparison Of Treatment In Real Life Situations (Pain-Controls)

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study Of The Efficacy, Safety, And Tolerability Of Oral Full-Spectrum Microbiot

  • Investigator: Bruce Yacyshyn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Cervical Diverticulum Prospective, Multi-Institutional Study Proposal

  • Investigator: Rebecca Howell
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase III Randomized Trial Of Blinatumomab For Newly Diagnosed Bcr-Abl Negative B Lineage Acute Lymphoblastic Leukemia In Adults

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2/3, Multi-Center, Open-Label, Randomized Study Of Weekly Nab?- Paclitaxel In Combination With Gemcitabine Or Carboplatin, Compared To Gemcita

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Study Of Oral Sapacitabine In Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Clinical Efficacy And Safety Of Subcutaneous Administration Of An Investigational Drug In The Prophylactic Treatment Of Heredita

  • Investigator: Jonathan Bernstein
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Do You Have Depression And Have Tried Antidepressant Medication?

  • Investigator: Lesley Arnold
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Assessment Of Dha On Reducing Early Preterm Birth

  • Investigator: Emily Defranco
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Study Of The Selective Braf Kinase Inhibitor Gsk2118436 In Subjects With Advanced Non-Small Cell Lung Cancer And Braf Mutations

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A 2-Year, Multi-Center, Phase II, Open-Label, Fixed-Dose, Randomized Comparative Trial Of Azacitidine, With Or Without Deferasirox In Patients With Hi

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II/III Study Of Image-Guided Radiosurgery/Sbrt For Localized Spine Metastasis

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Bn-16-01- A Phase 0/1 Exploratory Pharmacokinetic And Pharmacodynamics Study Of Letrozole In Combination With Standard Therapy In Recurrent Gliomas.

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Pilot Study Prospectively Evaluating Treatment For Patients Based On Ercc1 (Excision Repair Cross-Complementing 1) For Advanced/

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Evaluation Of Trc105 In Combination With Bevacizumab For The Treatment Of Recurrent Or Progresisve Gliblastoma That Has Progressed On Bevaci

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase IIb Randomized, Double Blind, Comparative Study To Assess The Efficacy, Safety, Tolerability And Inhibition Of Ovulation Of Two Continuous Reg

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Nrg-Hn004- Randomized Phase II/III Trial Of Radiotherapy With Concurrent Medi4736 (Durvalumab) Vs. Radiotherapy With Concurrent Cetuximab In Patients With Stage III-Ivb Head And Neck Cancer With A Contraindication To Cisplatin

  • Investigator: Vinita Takiar
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Fulvestrant Alone Versus Fulvestrant And Everolimus Versus Fulvestrant, Everolimus And Anastrozole: A Phase III Randomized Placebo-Controlled Trial I

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Glycemia Reduction Approaches In Diabetes: A Comparative Effectiveness Study

  • Investigator: Robert Cohen
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Traditional Versus Early Aggressive Therapy For Multiple Sclerosis (Treat-Ms) Trial

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1A

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Comparison Of Hemorrhagic And Ischemic Strokes Among Blacks And Whites: A Population-Based Study In Greater Cincinnati, Ohio

  • Investigator: Brett Kissela
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Randomized, Double-Blinded, Placebo-Controlled Phase II Study Of Adjuvant Everolimus Following The Resection Of Metastatic Pancreatic Neuroendocrine

  • Investigator: Shimul Shah
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Nrg-Gu006- A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial Of Salvage Radiotherapy With Or Without Enhanced Anti-Androgen Therapy With Apalutamide In Recurrent Prostate Cancer.

  • Investigator: Timothy Struve
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• High-Intensity Interval Training In Chronic Stroke

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase 1B, Open Label Study Of Dalantercept Plus Sorafenib In Patients With Advanced Hepatocellular Carcinoma

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Pragmatic Phase III Randomized Trial Of Proton Vs. Photon Therapy For Patients With Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiati

  • Investigator: Teresa Meier
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Study Of Irinotecan And Cetuximab With Or Without Vemurafenib In Braf Mutant Metastatic Colorectal Cancer.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Enroll-Hd

  • Investigator: Andrew Duker
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase III Trial Evaluating Both Erlotinib And Chemoradiation As Adjuvant Treatment For Patients With Resected Head Of Pancreas Adenocarcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase 3 Trial Comparing Vintafolide (Ec145) And Pegylated Liposomal Doxorubicin (Pld/Doxil?/Caelyx?) In Combination Versus P

  • Investigator: Eric Eisenhauer
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase I Open-Label Study To Evaluate The Effect Of Multiple Doses Of Azd1775 On The Pharmacokinetics Of Substrates For Cyp3a, Cyp2c19, Cyp1a2 And To

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Exceptional Responders Pilot Study: Molecular Profiling Of Tumors From Cancer Patients Who Are Exceptional Responders

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Novel Biomarker Study In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme (Gbm)

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Randomized Phase III Study Of Sorafenib Versus Stereotatic Body Radiation Therapy Followed By Sorafenib In Hepatocellular Carcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Phase II Trial Of Intermittent Versus Continuous Dosing Of Dabrafenib (Nsc-763760) And Trametinib (Nsc-763093) In Brafv600e/K Mutant Mel

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of Hsp90 Inhibitor At13387 Alone And In Combination With Crizotinib In The Treatment Of Non-Small Cell Lung Cancer (Nsclc)

  • Investigator: Nagla Abdel Karim
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Trial Of Smo/ Akt/ Nf2/Cdk Inhibitors In Progressive Meningiomas With Smo/ Akt/ Nf2/Cdk Pathway Mutations

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug